Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial (Q45405108)
Jump to navigation
Jump to search
scientific article published in April 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial |
scientific article published in April 2007 |
Statements
1 reference
Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial (English)
1 reference
Beatriz Grinsztejn
1 reference
Bach-Yen Nguyen
1 reference
Jose M Gatell
1 reference
Daniel Vittecoq
1 reference
Charles J Gonzalez
1 reference
Joshua Chen
1 reference
Charlotte M Harvey
1 reference
Robin D Isaacs
1 reference
Protocol 005 Team
1 reference
1 April 2007
1 reference
1 reference
Identifiers
1 reference